OKYO Pharma Limited is a British biotechnology company focused on the discovery and development of novel therapeutics for the treatment of inflammatory diseases and cancer. With a strong emphasis on research and development, OKYO Pharma is rapidly advancing its pipeline of innovative drugs targeting unmet medical needs.
